Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-09

Clinical Trial Update: Combined Multi-marker Screening and Treatment With Aspirin for Pre-eclampsia Prevention [Phase 3]

View source ↗

Summary

Phase 3 trial update on combined multi-marker screening and aspirin treatment for preeclampsia prevention; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Rabin Medical Center | Conditions: Preeclampsia | Phase 3 | Status: COMPLETED